Suchergebnisse - "Neurath, Markus F"

PubPharm (26)

1

Very Low-Volume, High-Intensity Interval Training Mitigates Negative Health Impacts of COVID-19 Pandemic-Induced Physical Inactivity

enthalten in: International journal of environmental research and public health | 2022

von Reljic, D. | Eichhorn, A. | Herrmann, H. | +2

2

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease : a prospective cohort study

enthalten in: The Lancet. Rheumatology | 2022

von Simon, D. | Tascilar, K. | Fagni, F. | +30

3

Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 infection

enthalten in: ResearchSquare.com | 2022

von Simon, D. | Tascilar, K. | Krönk, G. | +28

4

Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2022

von Simon, D. | Tascilar, K. | Kleyer, A. | +26

5

Intensity and longevity of SARS-CoV-2 vaccination response and efficacy of adjusted vaccination schedules in patients with immune-mediated inflammatory disease

enthalten in: bioRxiv.org | 2022

von Simon, D. | Tascilar, K. | Fagni, F. | +29

6

SMYD2 Inhibition Downregulates TMPRSS2 and Decreases SARS-CoV-2 Infection in Human Intestinal and Airway Epithelial Cells

enthalten in: Cells | 2022

von Yu, Y. | Herrmann, A. | Thonn, V. | +4

7

Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS– CoV‐2 in an Unvaccinated Cohort

enthalten in: Arthritis & Rheumatology | 2022

von Simon, D. | Tascilar, K. | Kleyer, A. | +26

8

COVID-19 and immune-mediated inflammatory diseases : effect of disease and treatment on COVID-19 outcomes and vaccine responses

enthalten in: The Lancet. Rheumatology | 2021

von Fagni, F. | Simon, D. | Tascilar, K. | +4

9

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

enthalten in: Annals of the rheumatic diseases | 2021

von Haberman, R. | Herati, R. | Simon, D. | +23

UpdateOf: medRxiv. 2021 May 12;:. - PMID 34013285

10

COVID-19 : biologic and immunosuppressive therapy in gastroenterology and hepatology

enthalten in: Nature reviews. Gastroenterology & hepatology | 2021

von Neurath, M.